{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:36:41Z","timestamp":1784335001351,"version":"3.55.0"},"reference-count":20,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T00:00:00Z","timestamp":1095724800000},"content-version":"vor","delay-in-days":51,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Basic Clin Pharma Tox"],"published-print":{"date-parts":[[2004,8]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold> Mechanism of protection against cisplatin nephrotoxicity in streptozotocin\u2010diabetic rats is unclear but is associated with decreased renal platinum accumulation. This study was designed to determine whether normalization of hyperglycaemia by insulin treatment to six week streptozotocin\u2010diabetic rats reversed protection against cisplatin nephrotoxicity. Male Sprague\u2010Dawley rats divided into 3 groups (n=10\/group) (1) non\u2010diabetic (2) untreated streptozotocin\u2010diabetic and (3) insulin\u2010treated streptozotocin\u2010diabetic groups were rendered diabetic using streptozotocin (65 mg\/kg body weight, intravenous). At the end of 6 weeks, Group 3 animals were treated with insulin (subcutaneously) for 21 days to normalize glucose. After 21 days of insulin treatment, the mean\u00b1S.D. plasma glucose (mg%) in Group 3 animals at 144.8\u00b122.03, was significantly lower than Group 2 animals (412\u00b124.69) and comparable to age\u2010matched non\u2010diabetic (Group 1) animals. Blood urea nitrogen at 24 hr after intraperitoneal administration of cisplatin (5 mg\/kg body weight) increased by a factor 2.5 in Group 3 compared to 1.1 and 1.3 in Group 1 and Group 2 animals respectively. In the same animals, at 96 hr the blood area nitrogen increased by a factor of 3.2 and 2.9 in Group 1 and Group 3 respectively compared to 1.14 for Group 2 animals. Renal platinum levels in Group 1, Group 2 and Group 3 after 96 hr after cisplatin administration were 6.92\u00b10.83, 3.46\u00b10.77 &amp; 6.20\u00b10.64 (\u03bcg\/g wet weight of tissue) respectively. Results indicate that 21 day insulin treatment to streptozotocin\u2010diabetic animal reverses protection against cisplatin toxicity. Moreover, insulin treatment increased the susceptibility of streptozotocin\u2010diabetic rats to cisplatin\u2010induced renal toxicity.<\/jats:p>","DOI":"10.1111\/j.1742-7843.2004.950204.x","type":"journal-article","created":{"date-parts":[[2004,9,21]],"date-time":"2004-09-21T09:52:38Z","timestamp":1095760358000},"page":"66-71","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Early Onset of Cisplatin\u2010Induced Nephrotoxicity in Streptozotocin\u2010Diabetic Rats Treated with Insulin*"],"prefix":"10.1111","volume":"95","author":[{"given":"Rangaprasad","family":"Sarangarajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Cacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2004,9,21]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-197-43257"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-203-43610"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(83)90299-0"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-206-43785"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0773.2002.900402.x"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)63035-0"},{"key":"e_1_2_6_8_1","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s00280-002-0537-0","article-title":"Inhibition of basolateral transport and cellular accumulation of cDDP and N\u2010acetyl\u2010L\u2010cysteine\u2010cDDP by TEA and PAH in the renal proximal tubule","volume":"51","author":"Kolb R. J.","year":"2003","journal-title":"Cancer Chemother. Pharmacol."},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1203\/00006450-199602000-00009"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/icb.1994.17"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/toxsci\/47.2.181"},{"key":"e_1_2_6_12_1","first-page":"12","volume-title":"The laboratory rat: Biology and disease","author":"Ringler D. H.","year":"1979"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-212-44027"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1997.tb02068.x"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1999.tb00087.x"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/0272-0590(89)90026-2"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1982.67"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.300.1.142"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(89)90165-0"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/0300-483X(90)90194-L"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-0461(1998)12:4<219::AID-JBT4>3.0.CO;2-O"}],"container-title":["Basic &amp; Clinical Pharmacology &amp; Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-7843.2004.950204.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1742-7843.2004.950204.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T07:05:51Z","timestamp":1697267151000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-7843.2004.950204.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["10.1111\/j.1742-7843.2004.950204.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1742-7843.2004.950204.x","archive":["Portico"],"relation":{},"ISSN":["1742-7835","1742-7843"],"issn-type":[{"value":"1742-7835","type":"print"},{"value":"1742-7843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,8]]},"assertion":[{"value":"2004-09-21","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}